GY, B., S, S., R, X., A, B., KM, O., P, J., . . . B, S. (2025). Widespread genomic heterogeneity at the type II NAD(P)H dehydrogenase locus predisposes Cryptosporidium to clofazimine resistance. BioRxiv : the preprint server for biology. https://doi.org/10.1101/2025.10.07.680968
Chicago Style (17th ed.) CitationGY, Buenconsejo, et al. "Widespread Genomic Heterogeneity at the Type II NAD(P)H Dehydrogenase Locus Predisposes Cryptosporidium to Clofazimine Resistance." BioRxiv : The Preprint Server for Biology 2025. https://doi.org/10.1101/2025.10.07.680968.
MLA (9th ed.) CitationGY, Buenconsejo, et al. "Widespread Genomic Heterogeneity at the Type II NAD(P)H Dehydrogenase Locus Predisposes Cryptosporidium to Clofazimine Resistance." BioRxiv : The Preprint Server for Biology, 2025, https://doi.org/10.1101/2025.10.07.680968.